Results 171 to 180 of about 1,629,755 (308)

Risk-based redesign of internal quality control procedures for emergency immunoassays in clinical laboratories: a multicenter study from China. [PDF]

Front Med (Lausanne)
Xiao G, Hu J, Liu Y, Zhao S, Liao W, Wang H, Zhang S.   +6 more
europepmc   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

Molecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu, Nicolas J. Niklaus, Anna M. Schläfli, Igor Tokarchuk, Magali Humbert, Federico La Manna, Bich Vu, David Maul, Ramin Radpour, Marianna Kruithof‐de Julio, Inti Zlobec, Jörn Dengjel, Bruce E. Torbett, Mario P. Tschan   +13 more
wiley   +1 more source

A Small-Scale Regional External Quality Assessment of Nucleic Acid Amplification Tests for Bordetella pertussis in China. [PDF]

J Clin Lab Anal
Guo Y, Zhou J, Li Z, Xiao J, Li T, Niu C, Luo Y.   +6 more
europepmc   +1 more source

Laboratory Questionnaire; The Laboratory [PDF]

Journal of Chemical Education, 1925
openaire   +1 more source

How do Public Laboratories Collaborate with Industry? New Survey Evidence from France. [PDF]

This paper uses a survey of 130 public laboratories in France to investigate collaborative activities of laboratories with industry. Our statistical analysis shows that knowledge and technology development and transfer occurs most frequently through ...
Goddard, John Gabriel, Isabelle, Marc
core  

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Performance of carbapenemase screening algorithms for detection of OXA-244-producing <i>Escherichia coli</i>. [PDF]

JAC Antimicrob Resist
Keizer KN, Harryvan TJ, Maat I, Vainio SJ, Vlek ALM, Melles DC, Rentenaar RJ, Groothuis DE, Kluytmans JAJW, Frakking FNJ.   +9 more
europepmc   +1 more source

Laboratory

American Journal of Public Health and the Nations Health, 1934
openaire   +3 more sources

Environment Restoration Operations Consolidated Quarterly Report - July 2015

, 2015
62 pagesEnvironmental Restoration Operations Consolidated Quarterly Report, July 2015 for the Department of Energy, National Nuclear Security Administration, Sandia National Laboratories that addresses all quarterly reporting (January through March 2015)
Sandia National Laboratories/NM
core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

Molecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington, Divya L. Dayanidhi, Mohammad Zokaasadi, John B. Mantyh, Pelumi D. Olawuni, Gabrielle Rupprecht, Jeremy M. Force, Shannon McCall, Ashwani K. Bahl, David S. Hsu, Jason A. Somarelli   +10 more
wiley   +1 more source